Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 21, 2015 10:16 AM ET


Company Overview of Rempex Pharmaceuticals, Inc.

Executive Profile

Daniel D. Burgess

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 7 different industries.

See Board Relationships


Mr. Daniel D. Burgess, also known as Dan, has been a Venture Partner of SV Life Sciences Advisers LLP since joining in June 2, 2014. Mr. Burgess is a part of SV Life Sciences Advisers LLP’s biotechnology investment team. Previously, he was the Founder and President of Rempex Pharmaceuticals, Inc., since May 2007 and served as its Chief Executive Officer. Mr. Burgess served as the Chief Executive Officer and President of Mpex Pharmaceuticals Inc., since May 22, 2007. ...

Corporate Headquarters

11535 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-875-2840
Fax: 858-875-2851

Board Members Memberships

Chief Executive Officer, President and Director
Former Director and Chairman of Audit Committee
Independent Director and Chairman of Audit Committee


Stanford University
Harvard Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rempex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at